Lekoklar

Clarithromycin, the active ingredient in Lekoklar, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Lekoklar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is used to treat infections caused by susceptible bacteria in several organ systems. - Community‑acquired pneumonia: eradicates the causative bacteria and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute otitis media: eliminates middle‑ear pathogens and relieves pain. - Skin and soft‑tissue infections: combats skin‑associated bacterial strains and promotes healing. - Helicobacter pylori eradication: part of combination therapy to eradicate H. pylori infection.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: increased bowel movements, sometimes watery. - Taste disturbance: altered or metallic taste perception. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - QT interval prolongation: potential cardiac arrhythmia risk. - Severe allergic reactions: including anaphylaxis, rash, or angioedema.

Before using clarithromycin, consider the following safety measures. - Renal impairment: assess kidney function and adjust therapy if needed. - Hepatic dysfunction: use with caution in patients with liver disease. - Cardiac history: monitor ECG for QT prolongation in at‑risk individuals. - Pregnancy: risk category unknown; evaluate benefits versus potential risks. - Drug interactions: review all concomitant medications for possible interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Clarithromycin can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise clarithromycin levels. - Ergot alkaloids: risk of ergotism due to increased exposure. - Warfarin: enhanced anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Statins metabolized by CYP3A4 (e.g., simvastatin): monitor for myopathy. - Theophylline: possible increase in plasma concentration. - Carbamazepine: may reduce clarithromycin effectiveness.